Predominant role for C5b-9 in renal ischemia/reperfusion injury
Top Cited Papers
Open Access
- 15 May 2000
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (10) , 1363-1371
- https://doi.org/10.1172/jci8621
Abstract
Previous work has indicated that complement is a mediator of ischemia/reperfusion (I/R) injury. To investigate the components of complement responsible for this effect, we examined a model of renal I/R injury in C3-, C4-, C5-, and C6-deficient mice. We occluded the renal arteries and veins (40–58 minutes) and, after reperfusion (0–72 hours), assessed renal structural and functional injury. C3-, C5-, and C6-deficient mice were protected from renal I/R injury, whereas C4-deficient mice were not protected. C6-deficient mice treated with antibody to block C5a generation showed no additional protection from I/R injury. Reconstitution with C6 alone restored the I/R injury in C6-deficient mice. Tubular epithelial cells were the main structures damaged by complement-mediated attack, and, in contrast, the renal vessels were spared. Neutrophil infiltration and myeloperoxidase activity were reduced in C-deficient mouse kidney, but by a similar extent in C3-deficient and C6-deficient mice. We conclude that the membrane attack complex of complement (in which C5 and C6 participate) may account for the effect of complement on mouse renal I/R injury. Neither C5a-mediated neutrophil infiltration nor the classic pathway, in which C4 participates, appears to contribute to I/R injury in this model. By contrast with other organs, such as the heart, the primary effect of complement in the ischemic area is on the parenchymal cell rather than the vascular endothelial cell. The membrane attack complex of complement is a potential target for prevention of I/R injury in this model.Keywords
This publication has 62 references indexed in Scilit:
- TGF-βbgr;1 stimulates the release of pre-formed bFGF from renal proximal tubular cellsKidney International, 1999
- Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Complement C6 and C2 Biosynthesis in Syngeneic PVG/c− and PVG/c+ Rat StrainsScandinavian Journal of Immunology, 1997
- Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaineAmerican Heart Journal, 1997
- Epithelial exposure to hypoxia modulates neutrophil transepithelial migration.The Journal of Experimental Medicine, 1996
- Fibronectin production by human tubular cells: The effect of apical proteinKidney International, 1996
- Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.The Journal of Experimental Medicine, 1996
- Alternative pathway activation of complement by cultured human proximal tubular epithelial cellsKidney International, 1994
- Assessment of myeloperoxidase activity in whole rat kidneyJournal of Pharmacological Methods, 1990
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990